510(k)

K061812: COMBI SCAN 500 URINE TEST STRIP ANALYZER, MODEL A93005

FDA 510(k) · Analyticon Biotechnologies AG · decided Apr 6, 2007

Key facts

510(k) number K061812
Device name COMBI SCAN 500 URINE TEST STRIP ANALYZER, MODEL A93005
Applicant Analyticon Biotechnologies AG
Product code JIL
Subsequent product codes CDM, CEN, JIN, JIO, JIR, JJB, JMA, JMT, KQO, LJX
Date received Jun 26, 2006
Decision date Apr 6, 2007
Decision Substantially equivalent (SESE)
Submission type Traditional
Review panel Clinical Chemistry
Medical specialty Clinical Chemistry

At a glance

  • None MAUDE adverse event reports
  • None Recall events
  • None UDI device identifiers (GUDID)
  • 1–9 Predicate devices cited
  • None Later submissions citing this device
  • 10–99 510(k)s with this product code
  • Yes 510(k) summary on file
  • No 510(k) statement on file
  • Not listed On the FDA AI-enabled device list

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Reading a 510(k)

Decision
SESE means the FDA found the device substantially equivalent to its predicate, so it may be marketed in the United States.
Predicates
Each clearance cites one or more legally marketed devices; the chain of predicates shows where a technology came from.
Product code
The three-letter code sets the device type, class and regulation, and groups competing clearances.
Summary or statement
Applicants file either a 510(k) summary of the safety and effectiveness information or a statement that it is available on request.

About 510(k) premarket notifications

A 510(k) is a premarket submission made to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device.

Source: U.S. Food and Drug Administration (FDA), 510(k) Premarket Notification database · Source date:

Browse all 510(k) premarket notifications